Srinivas Akkaraju

Director, 10% Owner · 2 filings · Latest: Feb 19, 2026

Kalaris Therapeutics, Inc.

Mineralys Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
KLRS	Srinivas Akkaraju	Director, 10% Owner	Dec 18, 2025	Purchase	$10.42	479,847	$5.0M	1,979,847	Feb 18 1:15 AM
—	AKKARAJU SRINIVAS	—	Dec 30, 2024	Proposed Sale	$0.2471	9,333	$2.3K	—	Dec 30 10:11 PM
SRRK	AKKARAJU SRINIVAS	—	Oct 7, 2024	Proposed Sale	$29.25	1,175,713	$34.4M	—	Oct 8 12:43 AM